Novadaq launches PINPOINT: Company's first minimally invasive imag...(orithm for the management of patients wi...),Health

Thoracic surgery is typically performed by heart surgeons who are already Novadaq's targeted customers for the SPY Imaging System. Additionally, thoracic surgeon specialists within the same practice, or specialists at cancer centers represent a synergistic and significant target market for PINPOINT. Protected by a significant portfolio of registered patents, PINPOINT does not require the administration of any contrast agent, but instead utilizes the fluorescence signal from the naturally occurring fluorophors in lung tissue to assist doctors in localizing pre-cancerous and cancerous lesions. It is expected that surgeons and specialists would use these enhanced imaging capabilities to plan and deliver minimally invasive treatments such as, PDT or Cryotherapy. A multi-center clinical trial of safety and effectiveness demonstrated that the use of Novadaq's autofluorescence imaging technology resulted in a 325% per lesion and a 250% per patient improvement in the detection of early stage lung cancers compared to conventional white light bronchoscopy. Another clinical study of 151 patients showed that autofluorescence was more sensitive than flexible video bronchoscopy (FVB). Autofluorescence effectively identified 96% or more of lesions of moderate dysplasia, compared to only 72% with FVB, as referenced in the ACCP guidelines.

"PINPOINT further deepens our value proposition to the Cardiothoracic surgical specialty and furthers the agenda for more minimally invasive image guided surgeries," said Dr. Arun Menawat, President and CEO of Novadaq Technologies, Inc. "Bronchoscopy is routinely done, but conducting the same procedure using PINPOINT allows surgeons to capture images that are proven to be far more clinically relevant and may lead to better patient care and outcomes including the potential to save lives."

About Novadaq Technologies

Novadaq Technologies Inc. (TSX: NDQ) develops and comm
'/>"/>